593.9500 -11.30 (-1.87%)
NSE Apr 04, 2025 15:31 PM
Volume: 583.7K
 

Emkay
KIMS’s Q3FY25 revenues were ahead of Street/our estimates, while profitability lagged owing to certain write-offs in Maharashtra and AP clusters, and losses in the Nashik hospital.
Promoters unpledged 3.22% of shares in last quarter. Total pledge stands at 12.13% of promoter holdings
More from Krishna Institute of Medical Sciences Ltd.
Recommended